Sunil Verma: A great way to kick off 2024 by attending JPM2024
Sunil Verma, Global Head of Oncology of Medical AstraZeneca, shared a post on LinkedIn:
”A great way to kick off 2024 by attending JPM2024. Join us as we discuss advancing research in clinic at Longwood Healthcare Leaders San Francisco CEO event, January 6-7, 2024.
As we embark on a new year, at AstraZeneca we are anchoring our work to address our Bold Ambition and strategic priorities—which emphasize the importance of sustainability—promoting healthy people, a healthy society and a healthy planet.
Health equity means that everyone has a fair and just opportunity to live a healthy life. For AstraZeneca, advancing health equity starts with ensuring there is inclusive participation in clinical trials. It is critical to have diversity represented in clinical trials to reduce biases, uncover new treatment approaches, and ultimately ensure all patients have access to our medicines and are provided the opportunity to achieve best possible health outcomes.
That’s why I’m pleased to be part of a panel discussion on “Advancing Research into the Clinic” at Longwood Healthcare Leaders San Francisco CEO event, January 6-7, 2024. I will be joined by leaders who share a passion and commitment to deliver life-changing medicines to all patients.
This industry-leading forum hosted by Longwood Healthcare Leaders focuses on a broad spectrum of topics affecting the biopharma ecosystem. Decision makers in the life sciences, including biopharma CEOs, heads of research and development, therapeutic area heads, leading academics, and life science investors will discuss a wide range of the most important issues facing healthcare today.
Looking forward to connecting with many of you attending JPM2024 and continuing to progress our collaboration towards a healthier society and a healthy planet. To learn more, visit the website.
About Longwood Healthcare Leaders: Longwood Healthcare Leaders hosts semiannual industry conferences with thought leaders and decision makers in government, pharma, biotech, and academia for off-the-record forums at institutions including Harvard Medical School and MIT to discuss areas of collaboration and access to innovation to accelerate the translation of discoveries into medicines to help patients. For more information, visit the link.”
Source: Sunil Verma/LinkedIn